Anti-Liver Cancer Compound Library

Catalog No. L2193

Globally, liver cancer, also known as Hepatic cancer, accounts for the third highest cancer mortality rate. The major causes of liver cancer include hepatitis B, hepatitis C, alcoholic steatohepatitis and non-alcoholic steatohepatitis (NASH). Multicellular signaling pathways are associated with hepatocarcinogenesis, such as PI3K/Akt/mTOR signaling pathway, epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), etc. The TargetMol Anti-Liver Cancer Compound Library is a collection of 1787 compounds related to liver cancer, including compounds that have been reported to have therapeutic effects in liver cancer, as well as compounds that target liver cancer-related targets, and is a good tool for anti-liver cancer drug development.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.